Cristina Tapioles-Nuevo
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
IF1 promotes oligomeric assemblies of sluggish ATP synthase and outlines the heterogeneity of the mitochondrial membrane potential.
Journal: Communications biology
Published: December 12, 2022
Analysis of the metabolic proteome of lung adenocarcinomas by reverse-phase protein arrays (RPPA) emphasizes mitochondria as targets for therapy.
Journal: Oncogenesis
Published: February 15, 2022
Effective therapeutic strategies in a preclinical mouse model of Charcot-Marie-Tooth disease.
Journal: Human molecular genetics
Published: June 16, 2021
Metformin as an Adjuvant to Photodynamic Therapy in Resistant Basal Cell Carcinoma Cells.
Journal: Cancers
Published: January 31, 2020
Metabolic reprogramming and disease progression in cancer patients.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: December 03, 2019
Overexpression of Mitochondrial IF1 Prevents Metastatic Disease of Colorectal Cancer by Enhancing Anoikis and Tumor Infiltration of NK Cells.
Journal: Cancers
Published: October 24, 2019
Coordinate β-adrenergic inhibition of mitochondrial activity and angiogenesis arrest tumor growth.
Journal: Nature communications
Published: April 05, 2019
PD-1 signaling affects cristae morphology and leads to mitochondrial dysfunction in human CD8+ T lymphocytes.
Journal: Journal for immunotherapy of cancer
Published: November 12, 2018
Overexpression of the ATPase Inhibitory Factor 1 Favors a Non-metastatic Phenotype in Breast Cancer.
Overexpression of the ATPase Inhibitory Factor 1 Favors a Non-metastatic Phenotype in Breast Cancer.
Journal: Frontiers in oncology
Published: January 16, 2017
Last Updated: 09/26/2026